Homepage | Lupus Science & Medicine
WEBLupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. An official journal of the Lupus Foundation of America (LFA), which is dedicated to advancing the science and medicine of lupus while offering support to ...
Editorial Board | Lupus Science & Medicine
WEBLupus Science & Medicine® Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests. Editors-in-Chief. Dr Jill Buyon, MD Declaration of Interests New York University School of Medicine New York, USA Area of expertise: Autoantibodies, Cytokines ...
Performance of the 2019 EULAR/ACR systemic lupus …
WEBPerformance of the 2019 EULAR/ACR systemic lupus erythematosus ...
Archive | Lupus Science & Medicine - Lupus Science & Medicine
WEBApr 1, 2014 · 13th Annual Meeting of the Lupus Academy, Hybrid Annual Meeting (Amsterdam), September 6–8, 2024. Vol 11, Issue 2. Vol 11, Issue Suppl 2. Lupus 21st Century 2023 Abstracts, September 27–30, Naples, Florida. Vol 11, Issue Suppl 1.
Table of contents | Lupus Science & Medicine
WEBOriginal research: Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN) Rebecca Williams-Hall, Pamela Berry, Nicola Williamson, Melissa Barclay, Anna Roberts, Adam Gater, Chloe ...
Authors | Lupus Science & Medicine - Lupus Science & …
WEBLupus Science & Medicine® is an open access journal and levies an Article Processing Charge (APC) of GBP 2,163 (exclusive of VAT for UK and EU authors). The APC for a Protocol, Brief communication or Letter is 1,082 GBP. There are no submission, colour or page charges. There is a 25% discount for articles where the corresponding author has ...
1005 Characterization of regulatory receptors on plasmacytoid …
WEBRegulatory or suppressive receptors on plasmacytoid dendritic cells (PDCs) are an attractive therapeutic target in systemic lupus erythematosus (SLE), given the role type I interferon (IFN) plays in this disease. In this study, we determine whether SLE patient PDC regulatory receptor expression and function associates with disease features in SLE. We used quantitative multicolor flow cytometry ...
WEBThanoua etΔal Lupus Science Medicine 216e365 doi11136lupus21365 1 Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures Aikaterini Thanou , 1 Judith A James,1,2 Cristina Arriens , 1 Teresa Aberle,1 Eliza Chakravarty,1 Joseph Rawdon,1 Stavros Stavrakis,2 Joan T Merrill,1 Anca Askanase3 To cite: Thanou A, …
Most Read Articles | Lupus Science & Medicine
WEB19 January 2024. Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132. Daniel J Burge, Victoria P Werth, Susan A Boackle, James Posada. 7 February 2024. Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives.
About | Lupus Science & Medicine - Lupus Science & Medicine
WEBLupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology ...
Skip to content